All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F19%3A00078581" target="_blank" >RIV/00209805:_____/19:00078581 - isvavai.cz</a>

  • Alternative codes found

    RIV/00209805:_____/18:00078100 RIV/00216224:14110/19:00108450 RIV/00159816:_____/19:00071245 RIV/00209805:_____/19:00078100

  • Result on the web

    <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.25533" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.25533</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/hed.25533" target="_blank" >10.1002/hed.25533</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy

  • Original language description

    Background: Progress in radiation treatment of head and neck squamous cell carcinoma (HNSCC) deserves the studies focused on molecular predictors that would help to enhance individually tailored treatment. Methods: p16/epidermal growth factor receptor (EGFR)/cluster of differentiation-44 (CD44) was immunohistochemically analyzed in 165 HNSCC patients. Results: In the entire group and the p16 negative cohort, better 3-year overall survival and locoregional control correlated with p16 positivity, CD44, and EGFR negativity were observed. Combined analysis revealed the worst results in the CD44+/p16-, EGFR+/p16-, and EGFR+/CD44+ groups and in the EGFR+/CD44+ within p16 negative cohort. Multivariate analysis found tumor stage, Karnofsky index, p16, and CD44 as prognostic factors of overall survival and clinical stage, and p16 as a prognostic factor for locoregional control. Clinical stage and Karnofsky index affected overall survival and tumor stage. EGFR affected locoregional control in the p16 negative subgroup. Conclusion: Our study confirmed the negative effect of CD44 and EGFR and the positive effect of p16 on radiotherapy results.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

  • Continuities

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Head &amp; neck.

  • ISSN

    1043-3074

  • e-ISSN

  • Volume of the periodical

    41

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    10

  • Pages from-to

    940-949

  • UT code for WoS article

    000461866800016

  • EID of the result in the Scopus database

    2-s2.0-85058436354